pyroGlu-Leu inhibits the induction of inducible nitric oxide synthase in interleukin-1β-stimulated primary cultured rat hepatocytes.

Abstract

Pyroglutamyl leucine (pyroGlu-Leu), which is a peptide isolated from wheat gluten hydrolysate, has been reported to be a hepatoprotective compound in acute liver failure. In inflamed liver, proinflammatory cytokines including interleukin (IL)-1β and tumor necrosis factor (TNF)-α stimulate the induction of inducible nitric oxide synthase (iNOS). Excess production of nitric oxide (NO) by iNOS is an inflammatory biomarker in liver injury. We examined proinflammatory cytokine-stimulated hepatocytes as a simple "in vitro inflammation model" to determine liver protective effects of pyroGlu-Leu and its mechanisms of action. We hypothesized that pyroGlu-Leu inhibits the induction of iNOS gene expression, resulting in the attenuation of hepatic inflammation. Hepatocytes were isolated from rats by collagenase perfusion and cultured. Primary cultured cells were treated with IL-1β in the presence or absence of pyroGlu-Leu. The induction of iNOS and its signaling pathway were analyzed. IL-1β stimulated the enhancement of NO production in hepatocytes and this effect was inhibited by pyroGlu-Leu. pyroGlu-Leu decreased the expression of iNOS protein and its mRNA. Transfection experiments with iNOS-luciferase constructs revealed that pyroGlu-Leu inhibited both of iNOS promoter transactivation and its mRNA stabilization. pyroGlu-Leu also decreased the expression of an iNOS gene antisense transcript, which is involved in iNOS mRNA stability. However, pyroGlu-Leu had no effects on IκB degradation and NF-κB activation. Results demonstrate that pyroGlu-Leu inhibited the induction of iNOS gene expression at transcriptional and post-transcriptional steps through IκB/NF-κB-independent pathway, leading to the prevention of NO production. pyroGlu-Leu may have therapeutic potential for liver injury through the suppression of iNOS.

• Authors: Masaharu Oishi, Tamami Kiyono, Kenji Sato, Katsuji Tokuhara, Yoshito Tanaka, Hirokazu Miki, Richi Nakatake, Masaki Kaibori, Mikio Nishizawa, Tadayoshi Okumura, Masanori Kon
• Journal: Nitric oxide : biology and chemistry (Nitric Oxide) Vol. 44 Pg. 81-7 (Jan 30 2015) ISSN: 1089-8611 [Electronic] United States
• PMID: 25512333 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2014 Elsevier Inc. All rights reserved.

Chemical References

• Dipeptides
• Interleukin-1beta
• NF-kappa B
• RNA, Messenger
• pyroglutamylleucine
• Nitric Oxide Synthase Type II
• Nos2 protein, rat
• Pyrrolidonecarboxylic Acid

Topics

• Animals
• Cells, Cultured
• Dipeptides (pharmacology)
• Hepatocytes (drug effects, metabolism)
• Interleukin-1beta (metabolism)
• Male
• NF-kappa B (metabolism)
• Nitric Oxide Synthase Type II (genetics, metabolism)
• Pyrrolidonecarboxylic Acid (analogs & derivatives, pharmacology)
• RNA, Messenger (genetics, metabolism)
• Rats
• Rats, Wistar
• Transcriptional Activation (drug effects)